0001209191-20-048298.txt : 20200825
0001209191-20-048298.hdr.sgml : 20200825
20200825190617
ACCESSION NUMBER: 0001209191-20-048298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200824
FILED AS OF DATE: 20200825
DATE AS OF CHANGE: 20200825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shameze Rampertab
CENTRAL INDEX KEY: 0001721810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 201133826
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP.
STREET 2: 3928 VARSITY DRIVE
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-24
0
0000876378
TRANSENTERIX, INC.
TRXC
0001721810
Shameze Rampertab
635 DAVIS DRIVE
SUITE 300
MORRISVILLE
NC
27560
0
1
0
0
EVP, Chief Financial Officer
Stock Option
0.42
2020-08-24
4
A
0
150000
0.00
A
2027-08-24
Common Stock
150000
150000
D
Restricted Stock Unit
2020-08-24
4
A
0
30000
0.00
A
Common Stock
30000
30000
D
Restricted Stock Unit
2020-08-24
4
A
0
20000
0.00
A
Common Stock
20000
20000
D
The stock options vest one-third annually on each of August 24, 2021, 2022 and 2023, as long as the Reporting Person remains in continuous service during the vesting period. Subject to acceleration of vesting in full upon consummation of a change in control of the Registrant.
Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the restricted stock units in three equal installments of 10,000 on each of July 1, 2021, 2022 and 2023, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan and the Reporting Person's Employment Agreement with the Registrant.
Represents performance-based restricted stock units with time-based vesting in three installments of 6,667, 6,667 and 6,666 on each of July 1, 2021, 2022 and 2023, and performance-based vesting only if, during the three year performance period ended August 24, 2023, the Registrant's stock price is equal to or greater than $1.00 for twenty consecutive trading days.
/s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab
2020-08-25